Molecular Templates Revenue vs. Current Valuation
| MTEM Stock | USD 0.37 0.03 7.50% |
Total Revenue | First Reported 2005-09-30 | Previous Quarter 11.1 M | Current Value 572 K | Quarterly Volatility 11.7 M |
For Molecular Templates profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Molecular Templates to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Molecular Templates utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Molecular Templates's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Molecular Templates over time as well as its relative position and ranking within its peers.
Molecular |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (3.05) | Revenue Per Share 4.544 | Quarterly Revenue Growth (0.92) | Return On Assets (0.38) |
The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Molecular Templates Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Molecular Templates's current stock value. Our valuation model uses many indicators to compare Molecular Templates value to that of its competitors to determine the firm's financial worth. Molecular Templates is regarded second in revenue category among its peers. It is rated below average in current valuation category among its peers reporting about 0.02 of Current Valuation per Revenue. The ratio of Revenue to Current Valuation for Molecular Templates is roughly 41.61 . At this time, Molecular Templates' Total Revenue is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Molecular Templates by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Molecular Revenue vs. Competition
Molecular Templates is regarded second in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 200.28 Million. Molecular Templates totals roughly 57.31 Million in revenue claiming about 29% of equities under Health Care industry.
Molecular Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Molecular Templates |
| = | 57.31 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Molecular Templates |
| = | 1.38 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Molecular Current Valuation vs Competition
Molecular Templates is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 530.26 Million. Molecular Templates adds roughly 1.38 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Molecular Templates Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Molecular Templates, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Molecular Templates will eventually generate negative long term returns. The profitability progress is the general direction of Molecular Templates' change in net profit over the period of time. It can combine multiple indicators of Molecular Templates, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -75.9 K | -79.7 K | |
| Operating Income | -10.5 M | -11 M | |
| Net Loss | -8.1 M | -8.5 M | |
| Income Tax Expense | -11 K | -10.4 K | |
| Income Before Tax | -8.1 M | -8.5 M | |
| Total Other Income Expense Net | 2.3 M | 2.2 M | |
| Net Loss | -26.2 M | -27.5 M | |
| Non Operating Income Net Other | -3.9 M | -4.1 M | |
| Net Loss | -83.4 M | -79.3 M | |
| Interest Income | 1.5 M | 892.5 K | |
| Net Interest Income | -2.6 M | -2.4 M | |
| Change To Netincome | 14.4 M | 7.4 M | |
| Net Loss | (1.80) | (1.90) | |
| Income Quality | 5.15 | 5.41 | |
| Net Income Per E B T | 1.00 | 1.13 |
Molecular Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Molecular Templates. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Molecular Templates position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Molecular Templates' important profitability drivers and their relationship over time.
Use Molecular Templates in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Molecular Templates position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Templates will appreciate offsetting losses from the drop in the long position's value.Molecular Templates Pair Trading
Molecular Templates Pair Trading Analysis
The ability to find closely correlated positions to Molecular Templates could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Molecular Templates when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Molecular Templates - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Molecular Templates to buy it.
The correlation of Molecular Templates is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Molecular Templates moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Molecular Templates moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Molecular Templates can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Molecular Templates position
In addition to having Molecular Templates in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Beers Thematic Idea Now
Beers
Companies involved in production and distribution of domestic and international beer. The Beers theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
To fully project Molecular Templates' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Molecular Templates at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Molecular Templates' income statement, its balance sheet, and the statement of cash flows.